Filing Details

Accession Number:
0001387131-14-000147
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-15 17:00:13
Reporting Period:
2014-01-13
Filing Date:
2014-01-15
Accepted Time:
2014-01-15 17:00:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532232 Mitchell Krassan 6800 Broken Sound Parkway Nw
3Rd Floor
Boca Raton FL 33487
Evp, Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-13 7,500 $0.19 7,500 No 4 M Direct
Common Stock Disposition 2014-01-13 7,500 $5.73 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-01-13 7,500 $0.00 7,500 $0.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
158,203 2011-10-04 2020-05-01 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a 10b5-1 Sales Plan dated December 9, 2013.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.70 to $5.76, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.